Leukemia Clinical Trials in Florida

Showing 721-740 of 882 trials

TR(ACE) Assay Clinical Specimen Study

NCT02934360

The TR(ACE) Assay is a quantitative in vitro diagnostic test run on the TR(ACE) Instrument intended for the measurement of high molecular weight human DNA from plasma as an aid to monitoring disease progression or response to therapy or recurrent or residual disease.

Carcinoma, Non-Small-Cell LungBreast Neoplasms

Biological Dynamics450 participantsStarted Sep 2016

Encinitas, California, United States • Oceanside, California, United States • Santa Monica, California, United States +13 more locations

TERMINATEDPhase 149 miles

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

NCT01911325

This is a multi-center, open-label Phase Ib dose escalation part followed by a randomized double-blinded placebo controlled Phase II part. The Phase Ib part will determine the Maximum Tolerated Dose (MTD)/Recommended Phase II Dose (RP2D) of buparlisib in combination with docetaxel. Subsequently the MTD/RP2D will be investigated in a Phase II randomized trial in patients with advanced or metastatic squamous NSCLC.

Squamous Non-small Cell Lung Cancer

Novartis Pharmaceuticals27 participantsStarted Oct 2013

Fayetteville, Arkansas, United States • Tampa, Florida, United States • Worcester, Massachusetts, United States +13 more locations

PreviousPage 37 of 45Next

TR(ACE) Assay Clinical Specimen Study

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

Leukemia Trials in Other Cities

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Expanded Access Program of Ponatinib

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Evaluation of ClearLLab Leukemia and Lymphoma Panels

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Physiologic Definition of Bronchopulmonary Dysplasia

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Other Conditions in Florida